|
End-of-day quote
NYSE
|
||
| - USD | - |
|
| 08-20 | Pharma sector doubles down on AI amid hopes of slashing costs, timelines | RE |
| 08-19 | Moderna, Merck breakthrough could usher in wave of cancer vaccines | RE |
| Market Cap | 160B 137B 128B 117B 220B 15,313B 223B 1,514B 590B 7,684B 601B 588B 25,429B | P/E 2026 * |
17.6x | P/E 2027 * | 13.8x |
|---|---|---|---|---|---|
| Enterprise Value | 207B 178B 166B 152B 286B 19,857B 289B 1,963B 765B 9,965B 779B 762B 32,976B | EV / Sales 2026 * |
3.33x | EV / Sales 2027 * | 3.39x |
| Free-Float |
59.05% | Yield 2026 * |
6.13% | Yield 2027 * | 6.18% |
Last Transcript: Pfizer Inc
| Manager | Title | Age | Since |
|---|---|---|---|
Albert Bourla
CEO | Chief Executive Officer | 64 | 2018-12-31 |
Cecile Guegan
DFI | Director of Finance/CFO | 55 | 2026-08-15 |
Rady Johnson
CMP | Compliance Officer | 65 | 2013-11-30 |
| Director | Title | Age | Since |
|---|---|---|---|
Suzanne Johnson
BRD | Director/Board Member | 68 | 2007-08-31 |
Shantanu Narayen
BRD | Director/Board Member | 62 | 2013-09-26 |
Albert Bourla
CHM | Chairman | 64 | 2019-12-31 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.88% | +6.38% | +76.40% | +126.75% | 1,119B | |
| +1.07% | +3.80% | +50.73% | +62.78% | 651B | |
| +1.20% | +6.21% | +25.81% | +78.74% | 468B | |
| +1.02% | +5.77% | +43.09% | +47.70% | 374B | |
| +0.85% | +4.07% | +23.88% | +41.58% | 302B | |
| +1.26% | +6.81% | +1.59% | +14.67% | 259B | |
| +1.88% | +5.81% | +49.57% | +70.53% | 238B | |
| +1.59% | +2.09% | -15.52% | -52.29% | 208B | |
| +1.87% | +5.61% | +27.32% | +91.38% | 181B | |
| Average | +1.29% | +4.97% | +31.43% | +53.54% | 422.21B | |
| Weighted average by Cap. | +1.14% | +5.09% | +44.17% | +72.69% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 62.24B 53.3B 49.84B 45.63B 85.66B 5,957B 86.82B 589B 230B 2,989B 234B 229B 9,892B | 59.84B 51.24B 47.92B 43.87B 82.36B 5,727B 83.47B 566B 221B 2,874B 225B 220B 9,511B |
| Net income | 8.9B 7.62B 7.13B 6.53B 12.25B 852B 12.42B 84.22B 32.82B 427B 33.42B 32.69B 1,415B | 11.08B 9.49B 8.87B 8.12B 15.25B 1,060B 15.46B 105B 40.86B 532B 41.6B 40.69B 1,761B |
| Net Debt | 47.48B 40.66B 38.03B 34.81B 65.36B 4,545B 66.23B 449B 175B 2,281B 178B 174B 7,547B | 42.88B 36.72B 34.34B 31.44B 59.02B 4,104B 59.82B 406B 158B 2,060B 161B 157B 6,816B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Select your edition
All financial news and data tailored to specific country editions
